Conformance Assessment of PD-L1 Expression Between Primary Tumour and Nodal Metastases in Non-Small-Cell Lung Cancer

INTRODUCTION: Programmed death-ligand 1 (PD-L1) expression as measured by immunohistochemistry (IHC) has been employed to predict the efficacy of anti-PD-1/PD-L1 therapy. Nevertheless, heterogeneous PD-L1 expression represents a challenge for the selection of patients for anti-PD-1/PD-L1 therapy. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Haipeng, Chen, Xueyan, Lin, Dong, Zhang, Jing, Li, Chao, Zhang, Dianbao, Zhang, Xianfen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941607/
https://www.ncbi.nlm.nih.gov/pubmed/31920342
http://dx.doi.org/10.2147/OTT.S223643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941607/
https://www.ncbi.nlm.nih.gov/pubmed/31920342
http://dx.doi.org/10.2147/OTT.S223643

Ejemplares similares